heynow

hey whats wrong with Djais? I love the place

Eminem House of Blues Atlantic City, Atlantic City, NJ Sat, Jul 9, 2005 08:00 PM its gonna be sick .. 2,000 seats thats it !!!!!!!!!!!!!!!!!

Welcome to JERSEY

johhny rocks

The Foundation Room, the sixth in the House of Blues chain, is the most elaborate of its components. Designed to raise money for arts education, the room charges between $2,250 and $8,500 a year for concert entry rights. Food and beverages are separate. Decorated with Persian rugs and wood hand-carved in Tibet, the room really is a series of smaller alcoves, private enclosures and dining areas around a central bar. Slot manufacturers often purchase memberships to the Foundation Room, said Roger Gros, editor of Global Gaming Business Magazine. "In Las Vegas, everyone does business there," Gros said. "And this is a much nicer room than the one in Las Vegas. I'm really impressed." The House of Blues in Atlantic City also is the site of the chain's first nightclub. Worship, a three-level facility with an entrance on the first floor, will be a prototype for future House of Blues locations in Philadelphia and New York. Also on the first floor is the restaurant, which serves Southern-style cuisine for lunch and dinner. Signature dishes include a rack of baby back ribs with Jim Beam barbecue sauce and mashed sweet potatoes, fried shrimp, catfish nuggets and chicken gumbo. The goal is to add another dimension to Showboat, a hotel-casino where demographics skew in the 50- to 75-year-old age range. The hope is that House of Blues will attract a much younger customer at night, without alienating the existing older customers who typically arrive during the day, Snowden said.

parking .. if you can afford it $20.00 to any car jockey in AC will keep you up front . NIKKI BEACH .. glad to hear things are working much better .. FOUNDATION ROOM at the HOUSE OF BLUES ... killer place to bring your crew if you roll big like i do and can afford the $2,500 MEMBERSHIP FEE.. I WOULD RATHER SPEND 2,500 ON a great members only cliub than give it to the FcKING casino !! The official grand opening will unfold the weekend of July 8, featuring concerts by Counting Crows, Eminem and the Blues Brothers, which will feature Aykroyd, Jim Belushi and the Buddy Guy Band

Boston Red Sox slugger Johnny Damon was seen signing autographs and chatting with fans at the Nikki Beach club at Resorts in Atlantic City a few days back

the is JERSEY PAY TO PLAY STATE!

the drink size is 8 oz at best served in something that looks like an art decoo ash tray ..thats a problem in a town where you drink for free ...how about a nice drink size !!!!!!!! and where is the FOOOD

sold....

Djais is open for sure, its 4 blocks from me ..enjoy

Franks run a class A clean nice place . they are picking on the wrong guy

good luck Arturo

Town renews bar's license but imposes conditions Published in the Asbury Park Press 06/23/05 BY COASTAL MONMOUTH BUREAU BELMAR — After a 2 1/2-hour hearing that attracted more than 200 people, the Borough Council approved D'Jais' liquor license renewal with a number of conditions intended to reduce rowdyism and smooth relations with people living nearby. The popular beachfront bar has been under fire since April, when the Belmar Homeowners Association filed a complaint against renewing its license. The association cited an "exorbitant number of disruptive incidents," called for the borough to establish penalties against "animal bars," and asked that police officers be posted around D'Jais. The heated debate prompted the borough to impose 13 conditions on D'Jais' renewed license and ordered that the police chief and the bar owner assist the state Division of Alcoholic Beverage Control in determining if the bar's operations and occupancy levels are related to the homeowners' complaints. Wearing D'Jais T-shirts, supporters of bar owner Frank Sementa appeared en masse Wednesday night to oppose any restrictions to the bar's operation. But after testimony from the police chief, the Borough Council added conditions agreed to by Sementa. Those conditions include not admitting new patrons after 1 a.m. and stopping re-entry at 1:30 a.m., keeping sidewalks and exits clear, toning down music at 1:15 a.m., stopping liquor sales at 1:30 a.m., monitoring the number of drinks sold to patrons and coordinating with the police on the "shush patrol" in nearby neighborhoods. Sementa said he gathered 664 signatures on a petition supporting D'Jais "Residents and tourists have traditionally co-existed. They have socialized together, patronized the town's businesses together and enjoyed Belmar's charms together. This relationship has benefitted both groups," he said. "We urge the mayor and council to refrain from adopting regulations that would change the character of Belmar." Michael Repsha of Surf Avenue said "he sees no problem whatsoever" living near D'Jais but his brother could not take the noise and moved to Howell. "I moved to the area," he said. "I chose to live in the area. You don't like where you live, move out to Howell." Population changing Instead of moving out, many residents have moved into the borough, as Belmar has embarked on an ambitious redevelopment to transform the 1-square-mile town into a year-round community. While the borough remains one of the most popular summer resorts at the Jersey Shore, in recent years rental homes have been torn down for more expensive single-family homes. A lot of the permanent residents — many new faces — have lower tolerance levels for the often-rowdy behaviors of patrons of the old Belmar establishments, such as bars and restaurants that are open past midnight. Maureen McCaffery, president of the homeowners association, said she welcomes summer visitors but she wants a "cleaner, safer and quieter" Belmar with better quality of life. "We are just looking for a balance," she said. "I just have people destroying your property, I can't get a night's sleep. I have no problem people coming into town." Police Chief Jack Hill testified Wednesday that two police officers gathered data every week from May to mid-June about D'Jais' operation. He said D'Jais is well run with observant bouncers and an effective patrol of employees who ask patrons to be quiet in residential neighborhoods. Hill also said bartenders had trouble monitoring the number of drinks partons consume when D'Jais becomes crowded. But Hill said D'Jais has not violated the borough's noise ordinance or state Alcohol and Beverage Control regulations. He recommended that D'Jais stop admitting people at midnight, change their music tempo an hour earlier at 12:30 a.m and stop selling liquor at 1 a.m. Hill also said D'Jais should sell no more than two alcoholic drinks to a patron at one time, increase the number of security personnel in the bar and keep the line of people waiting outside to enter the bar to 75. Owner's lawyer objects William Wolf, Sementa's attorney, objected to imposing conditions on the license, and said the recommendations don't much match the findings by police and the state ABC board. "This is a well-run establishment and nothing should change," he said. "These conditions are unfair. They are discriminatory and they have detrimental and adverse effect on my client's business." After more testimony from Sementa, both sides agreed on some conditions. Mayor Kenneth Pringle said residents and businesses should respect each other and find a way to co-exist. William Kaiser, 52, of 19th Avenue, said D'Jais has been very quiet this year. "It's been so quiet since the last meeting that it's crazy." he said. "It's the best I have every seen. I don't like it personally. I like the noise."

couple fo my clam digging friends went down this past weekend Saturday nigh place was packed closed the line at 12:30am They got in, CASH IS KING

my place

Johnny Vicious

checked it out Wed. the weather was perfect, the drink were ok . they need better booze get some real Tequila like Cabo or Patrone and Gentlemna Jack Daniels ... I will be there for bottle service day crowd is not going to spend $8.00 for jack daniels & coke served in a 7 once cup .. very nice setup I wish Jack & the gang from Penrods the best of luck it aint easy in AC !!

Belmar is going to be very strict this year, be careful, the days are numbered..seems like the party will be moving to Atlantic City

i will check it out, I also cant wait till the House of Blues Foundation room opens in Atlantic City , im a gold member of the club in vegas and cant to see what they do in AC . I might pick up a VIP for Nikki while im down there, getting bored of the Borgata

if you took my advice last week, you would have made a KILLING in the market this week,.. its still all good for ELN...time to drink!!!! http://bbs.clubplanet.com/showthread.php?t=245510

NOT GUTS >>NO GLORY... you guys are young enought to take a shot.. this is the play of the year.. you can repay me with lap dances at scores this is an article you would never see.. Elan is an Irish Pharma company this article was in the Sunday Irsih Times.. Make or break for Elan's 'silver bullet' Sunday October 17th By Eamon Quinn The countdown has begun. Within weeks investors in Elan will know whether they have backed the single best high-risk bet on the Irish market, or whether - for the second time in three years - they hold the stock market equivalent of a beaten docket. The US watchdog, the Securities and Exchange Commission (SEC), is expected within days to deliver its verdict on Elan's former offshore and off-balance-sheet accounting practices. Then, in a much more significant development, the US Food and Drug Administration will deliver a decision by November 26 on its fast-tracked six-month study into Antegren, a potential wonder drug for the treatment of Multiple Sclerosis (MS), which Elan jointly owns with US partner Biogen Idec. Surprisingly, the SEC's ruling - after a two-year wait and after much concern that Elan would collapse under its own $1 billion (€800 million) of debt - is unlikely to unsettle the share price. Investors are clearly focused on a bigger prize than a favourable ruling from the SEC. Elan shares barely budged last week when it sold off its stake in fellow Irish drug firm Warner Chilcott. According to analysts, an SEC ruling that said Elan would have to pay a fine of less than $50 million (€40 million) would be viewed as just a mild censure. But it is the FDA decision on Antegren that will decide the fate of Elan shares. Analysts at Davy and Goodbody Stockbrokers predict that the current share price of $21 in New York (€17 in Dublin trading) could soar to around $30 following a favourable FDA review. "There's a concentration of events coming together in a matter of weeks with the SEC and the FDA,'' said Ian Hunter at Goodbody. "But Antegren is the key." The Sunday Business Post first highlighted the potential of Antegren in an interview a year ago with Lars Ekman, Elan's head of research and development. As noted at the time, Ekman abandoned the measured comments of his profession and talked enthusiastically about Antegren's potential for treating MS sufferers. He also talked about the outlook for the drug to be used also for Crohn's, a disease of the autoimmune system that leads to severe inflammation of the intestines. "Antegren provides the most valuable, exciting development I have personally seen in my career," he told this newspaper. "It is the reason I joined Elan two and a half years ago." In fast-tracking the trial for the drug, the FDA obviously also thought the same. It was an unprecedented move by the regulator. Never before in the history of MS treatments had the FDA ruled to cut the normal two-year period of testing on humans to only six months. When Ekman was speaking 12 months ago, Elan shares were trading around a quarter of their current value. what could happen to Elan shares if the FDA approves the drug next month? Or has the share price already reflected the good news for Antegren? The best scenario for Elan shareholders would be for the FDA to give full approval. The market would then pore over the test data to determine what share Antegren could capture of the €3.2 billion MS market, currently fought over by three drugs. The more successful it is found to be against the rival treatments, the greater the potential uplift for Elan. "I would like to think it would make $28 on the back of news flow like that," said Jack Gorman, analyst at Davy Stockbrokers. The rival MS drugs include Copaxone from Israeli company Teva and Rebif, produced by Serono of Switzerland. But the biggest share of the MS drug market is controlled by Biogen, the firm with which Elan has partnered to develop Antegren. Biogen owns outright the current best-selling MS drug, Avonex, and will have 50 per cent of the potential number one drug if the FDA data showed that Antegren were the superior drug. The huge upside for Elan shareholders would be the potential for Antegren to be manufactured and brought to market by Biogen by mid-2005. A Biogen plant in the US would make the drug and Biogen would sell it through its existing MS sales force. Elan would also sell Antegren through its smaller sales channel directly to US hospitals. Under the brightest scenario, which includes full FDA approval and proof that Antegren was effective in treating MS sufferers who currently do not respond to Avonex, the Elan share price will soar, Goodbody's Hunter predicted. "$31 will be reached very quickly," he said. The outlook also looks bright for Biogen shareholders, whose shares have already risen 55 per cent this year. Would investors, if convinced by the Antegren story, be better advised to buy Biogen rather than Elan? Davy's Gorman estimates that Avonex currently has 35 per cent of the of the market. "It's a fair way of looking at things," said Gorman. "But say that Antegren is streets ahead of Avonex - Biogen could have problems in that Antegren starts cannibalising Avonex revenues, and the earnings could be at risk in a quarter or two." Analysts said that with a less favourable outcome, the FDA could announce that the drug requires further tests. Investors will have to weigh that risk. A successful outcome for Antegren in November would open up Antegren to be prescribed for Crohn's Disease, even though the drug has not been filed in the US as a treatment for the disease. Nonetheless, physicians would be aware of the impending filing, and would probably substitute existing treatments for Antegren. A successful FDA approval would make it more likely, not less, that Elan would issue a long-mooted bond issue by the end of the year, according to analysts. The company has around $1 billion (€800 million) in debt, including the repayments due on the $390 million (€312 million) EPIL III vehicles (Elan Pharmaceutical Investments). A bond issue would help Elan to restructure its balance sheet. "It's shaping up to be quite an exciting couple of months for Elan shareholders," said Goodbody's Jack Gorman. The end of the article but the real beginning for the restructured Elan!

Elan is the best kept secret on the NYSE, just buy and hold the stock you will make the best return of any pharma stock. FDA approval next month http://www.elan.com/research_development/Antegren/default.asp

I have a Lincoln Nav & a BMW 745 2002 ..fianlly switched to GEICO saved 30% ..2 THOUSAND dollars baby ..more money for the bar & casino

BUY ELAN ... that is the stock to own ..its all about Antegren